@article{b926fddd582f42129653b63d2c0e532f,
title = "Risk of male breast cancer in users of testosterone 5a reductase inhibitors",
keywords = "adrenergic receptor blocking agent, androgen receptor, BRCA2 protein, steroid 5alpha reductase, cancer diagnosis, cancer registry, controlled study, death, diagnosis, drug exposure, gene inactivation, gene mutation, gynecomastia, human, logistic regression analysis, major clinical study, male, male breast cancer, population based case control study, proportional hazards model, prostate cancer, prostate hypertrophy, side effect",
author = "H.L. Olsson and J. Lindahl and P. Broberg",
year = "2016",
language = "English",
volume = "34",
journal = "Journal of Clinical Oncology",
issn = "1527-7755",
publisher = "American Society of Clinical Oncology",
number = "Suppl 15",
note = "2016 Annual Meeting of the American Society of Clinical Oncology, ASCO 2016 ; Conference date: 03-06-2016 Through 07-06-2016",
}
